Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 61-70 of 104 for alzheimer's

Edit search filters
  1. A study to create and analyze a comprehensive longitudinal resource using testing results from those with genetic risk of Alzheimer's disease

    Scottsdale/Phoenix, AZ

  2. Advancing Reliable Measurement in Alzheimer's Disease and Cognitive Aging

    Jacksonville, FL

  3. Reduced Genomic Diversity, Cognitive Aging, and Dementia Risk

    Scottsdale/Phoenix, AZ

  4. A Tool for Alzheimer’s Disease (AD) and AD-related Dementias Caregivers Addressing Financial Management and Legal Planning

    Rochester, MN

  5. A Study to Develop an EEG Diagnostic for Alzheimer’s Disease

    Rochester, MN, Scottsdale/Phoenix, AZ

  6. For Mild Cognitive Impairment (MCI) Patients and Their Caregivers: Bewell360 HWC Care Model for Mild Cognitive Impairment (MCI)

    Jacksonville, FL, Scottsdale/Phoenix, AZ

  7. Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD

    Rochester, MN

  8. TRC-PAD Program: In-Clinic Trial-Ready Cohort

    Rochester, MN, Jacksonville, FL

  9. Evaluation of Retinal Imaging in Patients with Alzheimer’s Disease

    Rochester, MN

  10. The Impact of Cognitive Impairment on Driving Safety.

    Rochester, MN

.

Mayo Clinic Footer